Literature DB >> 14651375

Directly observed short course therapy for tuberculosis--a preliminary report of a three-year experience in a teaching hospital.

Gregory E Erhabor1, Olufemi Adewole, Adewale O Adisa, Olufadeke A Olajolo.   

Abstract

SETTING: The Chest Clinic of Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife, southwest Nigeria is a referral center for tuberculosis patients in the region. Directly Observed Treatment Short Course (DOTS) has been in operation in the center since 1996.
OBJECTIVE: To review the outcome of patients on DOTS with the aim of determining factors that may influence compliance.
METHODS: Tuberculosis patients were placed on different treatment regimens according to the recommendation of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Nigerian Tuberculosis and Leprosy Control Program (NTBLCP). The results were recorded and evaluated periodically by the clinic staff under central supervision. The outcome of treatment over a three-year period (1996-1999) was reviewed.
RESULTS: Five-hundred-seventy-one patients were treated during this period. Cure/treatment completed rate was 86.1%, and compliance rate was 93.8%. Age, sex category of treatment, and distance from hospital had no significant influence on drug compliance.
CONCLUSION: DOTS is an effective means of administering anti-TB drugs. Efforts should be channeled towards developing strategies for implementing DOTS in a more efficient way.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651375      PMCID: PMC2594688     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  The global tuberculosis situation and the new control strategy of the World Health Organization.

Authors:  A Kochi
Journal:  Tubercle       Date:  1991-03

Review 2.  Directly observed therapy for tuberculosis: history of an idea.

Authors:  R Bayer; D Wilkinson
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

3.  A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen.

Authors:  D L Cohn; B J Catlin; K L Peterson; F N Judson; J A Sbarbaro
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

4.  Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994.

Authors:  D Wilkinson; G R Davies; C Connolly
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

Review 5.  Women and tuberculosis.

Authors:  M Connolly; P Nunn
Journal:  World Health Stat Q       Date:  1996

6.  Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance.

Authors:  F Manalo; F Tan; J A Sbarbaro; M D Iseman
Journal:  Am Rev Respir Dis       Date:  1990-12

Review 7.  When tuberculosis treatment fails. A social behavioral account of patient adherence.

Authors:  E Sumartojo
Journal:  Am Rev Respir Dis       Date:  1993-05

Review 8.  Tuberculosis. An old disease but a new threat to the mother, fetus, and neonate.

Authors:  J R Starke
Journal:  Clin Perinatol       Date:  1997-03       Impact factor: 3.430

9.  Tuberculosis, poverty, and "compliance": lessons from rural Haiti.

Authors:  P Farmer; S Robin; S L Ramilus; J Y Kim
Journal:  Semin Respir Infect       Date:  1991-12

10.  High-compliance tuberculosis treatment programme in a rural community.

Authors:  D Wilkinson
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321

View more
  3 in total

1.  From DOTS to the Stop TB Strategy: DOTS coverage and trend of tuberculosis notification in Ebonyi, southeastern Nigeria, 1998-2009.

Authors:  Kingsley Ukwaja; Isaac Alobu; Ngozi Ifebunandu; Chijioke Osakwe; Chika Igwenyi
Journal:  Pan Afr Med J       Date:  2011-05-31

2.  Treatment Outcome of Tuberculosis Patients Registered at DOTS Centre in Ogbomoso, Southwestern Nigeria: A 4-Year Retrospective Study.

Authors:  Olarewaju Sunday; Olanrewaju Oladimeji; Folorunso Ebenezer; Babatunde Akintunde; Temitayo-Oboh Abiola; Abdulsalam Saliu; Oluwatoyin Abiodun
Journal:  Tuberc Res Treat       Date:  2014-09-28

3.  A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment.

Authors:  Malvika Verma; Karan Vishwanath; Feyisope Eweje; Niclas Roxhed; Tyler Grant; Macy Castaneda; Christoph Steiger; Hormoz Mazdiyasni; Taylor Bensel; Daniel Minahan; Vance Soares; John A F Salama; Aaron Lopes; Kaitlyn Hess; Cody Cleveland; Daniel J Fulop; Alison Hayward; Joy Collins; Siddartha M Tamang; Tiffany Hua; Chinonyelum Ikeanyi; Gal Zeidman; Elizabeth Mule; Sooraj Boominathan; Ellena Popova; Jonathan B Miller; Andrew M Bellinger; David Collins; Dalia Leibowitz; Shelly Batra; Sandeep Ahuja; Manju Bajiya; Sonali Batra; Rohit Sarin; Upasna Agarwal; Sunil D Khaparde; Neeraj K Gupta; Deepak Gupta; Anuj K Bhatnagar; Kamal K Chopra; Nandini Sharma; Ashwani Khanna; Jayeeta Chowdhury; Robert Stoner; Alexander H Slocum; Michael J Cima; Jennifer Furin; Robert Langer; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2019-03-13       Impact factor: 17.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.